Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas C Wolf

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Inflammatory Bowel Diseases|March 3, 2016
Biosimilars in Crohn's Disease and Ulcerative ColitisDouglas C Wolf
Inflammatory Bowel Diseases|August 20, 2016
ReplyDouglas C Wolf
Inflammatory Bowel Diseases|August 12, 2003
Antibodies to "antibodies to tumor necrosis factor" and infusion reactions: is this infliximab's Achille's heel?Douglas C Wolf
Toxicologic Pathology|January 7, 2003
Use of the spontaneous Tsc2 knockout (Eker) rat model of hereditary renal cell carcinoma for the study of renal carcinogensKevin S McDorman, Douglas C Wolf
Toxicology and Applied Pharmacology|January 26, 2005
Confounders in interpreting pathology for safety and risk assessmentDouglas C Wolf, Peter C Mann
Critical Reviews in Toxicology|November 3, 2016
Response to letter to the editor from Chappelle, Spence, and Tury concerning Wolf et al. 2016: Illustrative case using the RISK21 roadmap and matrix: prioritization for evaluation of chemicals found in drinking water. 2016, Crit. Rev. Toxicol. Vol 46: 43-53Douglas C Wolf, Michelle R Embry
Mutation Research|May 4, 2004
The transcriptional profile of the kidney in Tsc2 heterozygous mutant Long Evans (Eker) rats compared to wild-typeBanalata Sen, Douglas C Wolf, Susan D Hester
The American Journal of Gastroenterology|June 10, 2020
Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth SubsalicylateDouglas C Wolf, Christine H Wolf, David T Rubin
Gastroenterology & Hepatology|January 25, 2013
Predicting Outcomes and Tailoring Therapy in the Diagnosis and Treatment of IBDEllen J Scherl, Ernest G Seidman, Douglas C Wolf
Critical Reviews in Toxicology|July 4, 2023
Is the 90-day dog study necessary for pesticide toxicity testing?Patricia L Bishop, Vicki L Dellarco, Douglas C Wolf
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Inflammatory Bowel Diseases|March 3, 2016
Biosimilars in Crohn's Disease and Ulcerative ColitisDouglas C Wolf
Inflammatory Bowel Diseases|August 20, 2016
ReplyDouglas C Wolf
Inflammatory Bowel Diseases|August 12, 2003
Antibodies to "antibodies to tumor necrosis factor" and infusion reactions: is this infliximab's Achille's heel?Douglas C Wolf
Toxicologic Pathology|January 7, 2003
Use of the spontaneous Tsc2 knockout (Eker) rat model of hereditary renal cell carcinoma for the study of renal carcinogensKevin S McDorman, Douglas C Wolf
Toxicology and Applied Pharmacology|January 26, 2005
Confounders in interpreting pathology for safety and risk assessmentDouglas C Wolf, Peter C Mann
Critical Reviews in Toxicology|November 3, 2016
Response to letter to the editor from Chappelle, Spence, and Tury concerning Wolf et al. 2016: Illustrative case using the RISK21 roadmap and matrix: prioritization for evaluation of chemicals found in drinking water. 2016, Crit. Rev. Toxicol. Vol 46: 43-53Douglas C Wolf, Michelle R Embry
Mutation Research|May 4, 2004
The transcriptional profile of the kidney in Tsc2 heterozygous mutant Long Evans (Eker) rats compared to wild-typeBanalata Sen, Douglas C Wolf, Susan D Hester
The American Journal of Gastroenterology|June 10, 2020
Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth SubsalicylateDouglas C Wolf, Christine H Wolf, David T Rubin
Gastroenterology & Hepatology|January 25, 2013
Predicting Outcomes and Tailoring Therapy in the Diagnosis and Treatment of IBDEllen J Scherl, Ernest G Seidman, Douglas C Wolf
Critical Reviews in Toxicology|July 4, 2023
Is the 90-day dog study necessary for pesticide toxicity testing?Patricia L Bishop, Vicki L Dellarco, Douglas C Wolf
Pageof 13